News

Pharmabiz49m
ICMR-NIREH to host workshop on ddPCR from August 11 to 14 with special emphasis on molecular virology
Shardul Nautiyal, Mumbai Saturday, July 5, 2025, 08:00 Hrs [IST] ...
Pharmabiz49m
Indian healthcare sector grapples with acute shortages of infrastructure & skilled professionals: Dr Raj Nagarkar
Indian healthcare sector grapples with acute shortages of infrastructure & skilled professionals: Dr Raj Nagarkar: Nandita Vijayasimha, Bengaluru Saturday, July 5, 2025, 08:00 Hrs ...
Pharmabiz49m
Govt support fuels Indian pharma growth amidst challenges: T Revichandran
The Union government's substantial and commendable support for the Indian pharmaceutical industry, particularly for the MSME sector, is evident. T. Revichandran, vice-president of IDMA South Region, ...
Pharmabiz49m
DCC recommends DCGI to share SOPs and formats with States as per IDP
DCC recommends DCGI to share SOPs and formats with States as per IDP: Gireesh Babu, New Delhi Saturday, July 5, 2025, 08:00 Hrs [IST] The Drugs Consultative Committee (DCC) has re ...
Pharmabiz20h
Pharmac South 2025 opened at Chennai Trade Centre today
Our Bureau, Chennai Friday, July 4, 2025, 12:45 Hrs [IST] Pharmac South 2025, the 10th edition of South India's high-power ...
Pharmabiz15h
Lupin introduces ipratropium bromide nasal solution, 0.03% & 0.06% in US markets
Lupin introduces ipratropium bromide nasal solution, 0.03% & 0.06% in US markets: Our Bureau, Mumbai Friday, July 4, 2025, 17:30 Hrs [IST] Global pharma major Lupin Limited (Lupin ...
Pharmabiz14h
CytoDyn announces encouraging clinical findings among patients with advanced metastatic colorectal cancer previously treated with leronlimab
CytoDyn announces encouraging clinical findings among patients with advanced metastatic colorectal cancer previously treated with leronlimab: Vancouver, Washington Friday, July 4, ...
Pharmabiz15h
Jaslok Hospital performs first-of-its-kind lutetium therapy saving terminal prostate cancer patient
Jaslok Hospital performs first-of-its-kind lutetium therapy saving terminal prostate cancer patient: Our Bureau, Mumbai Friday, July 4, 2025, 17:15 Hrs [IST] In a first-of-its-kin ...
Pharmabiz15h
Nuravax, Institute for Molecular Medicine to present phase 1 results & phase 2 design of Alzheimer’s vaccine AV-1959R at CTAD 2025
Nuravax, Institute for Molecular Medicine to present phase 1 results & phase 2 design of Alzheimer’s vaccine AV-1959R at CTAD 2025: Irvine, California Friday, July 4, 2025, 17:0 ...
Pharmabiz16h
PHARMASEAL announces Technical Integration Partnership with Viedoc
PHARMASEAL announces Technical Integration Partnership with Viedoc: Nottingham, UK Friday, July 4, 2025, 16:00 Hrs [IST] PHARMASEAL, provider of the Engility Trial Management Plat ...
Pharmabiz19h
Jacobio Pharma submits phase I/II IND application for its BET inhibitor, JAB-8263 to treat autoimmune diseases to CDE in China
Jacobio Pharma submits phase I/II IND application for its BET inhibitor, JAB-8263 to treat autoimmune diseases to CDE in China: Beijing, Shanghai Friday, July 4, 2025, 13:00 Hrs [ ...
Pharmabiz17h
Inmagene enrolls first patient in ADAPTIVE phase 2b clinical trial of IMG-007
Inmagene enrolls first patient in ADAPTIVE phase 2b clinical trial of IMG-007: San Diego Friday, July 4, 2025, 15:00 Hrs [IST] Inmagene Biopharmaceuticals (Inmagene), a clinical-s ...